Neodymium: YAG laser vitreolysis for treatment and prophylaxis of cystoid macular oedema.
Eighteen eyes with vitreous strands adherent to the corneoscleral wound of previous cataract surgery were treated with neodymium: YAG laser to achieve vitreolysis. Twelve eyes were treated for management of cystoid macular oedema (CMO group) and six eyes were treated for prophylaxis of possible CMO (prophylactic group). In the CMO group, visual acuity improved two or more Snellen lines in 10 eyes (83.3%) and seven eyes had a post-laser visual acuity of 20/40 or better (one eye had a pre-treatment visual acuity of 20/40 or better). In the prophylactic group, visual acuity was either maintained at the pre-treatment level or improved in five eyes (83.3%) eighteen months after laser treatment. This procedure was complicated by retinal detachment in one case and elevation of intraocular pressure over 10 mmHg in another case.
Tchah
H
H
Department of Ophthalmology, University of Minnesota, Minneapolis 55455.
Rosenberg
M
M
Larson
R S
RS
Lindstrom
R L
RL
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002387:Cataract Extraction / Q000009:adverse effects*; D005260:Female; D006801:Humans; D053685:Laser Therapy; D008269:Macular Edema / Q000209:etiology / Q000517:prevention & control / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D014792:Visual Acuity; D014821:Vitrectomy